364 results on '"Gazzard, Brian G."'
Search Results
2. The Evolution of Coreceptor Tropism in HIV-infected Patients Interrupting Suppressive Antiretroviral Therapy
3. When Should Antiretroviral Therapy for HIV Be Started?
4. Epidemiology and Predictive Factors for Chemokine Receptor Use in HIV-1 Infection
5. Rising Rates Of Hiv Infection: Preventive Measures Are Failing
6. Elevated Mucosal Addressin Cell Adhesion Molecule-1 Expression in Acquired Immunodeficiency Syndrome Is Maintained during Antiretroviral Therapy by Intestinal Pathogens and Coincides with Increased Duodenal CD4 T Cell Densities
7. Chemokine Receptor Polymorphisms and Human Immunodeficiency Virus Disease Progression
8. Clinical Efficacy of High-Dose Acyclovir in Patients with Human Immunodeficiency Virus Infection: A Meta-Analysis of Randomized Individual Patient Data
9. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM
10. Treatment for adult HIV infection: 2006 Recommendations of the international AIDS society-USA panel
11. Treatment for adult HIV infection
12. PCR-ELISA: a new simplified tool for tracing the source of cryptosporidiosis in HIV-positive patients
13. Delayed Gastric Emptying in Human Immunodeficiency Virus Infection
14. Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy: A Randomized Controlled Trial
15. A Risk-Benefit Assessment of HIV Protease Inhibitors
16. Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens
17. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy
18. Antiretroviral Therapy for HIV Infection: A Knowledge-Based Approach to Drug Selection and Use
19. Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals
20. Jejunal water and electrolyte transport in human cryptosporidiosis
21. Current Knowledge and Future Prospects for the Use of HIV Protease Inhibitors
22. Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals
23. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy
24. Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen
25. Treatment and Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients
26. An open-label assessment of TMC 125—a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance
27. Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection
28. Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy
29. Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?
30. A case of march fracture in a patient with osteoporosis on long-term HAART
31. The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml
32. Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel
33. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors
34. Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis
35. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma
36. Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis
37. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
38. Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study
39. True gynaecomastia, another manifestation of immune reconstitution disease?
40. Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection
41. Incidence and risk factors for the development of indinavir-associated renal complications
42. Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy
43. Cessation of secondary prophylaxis in patients with cryptococcosis
44. Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors
45. Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine
46. Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use
47. Efficacy of a Nelfinavir- and Nevirapine-Containing Salvage Regimen
48. Frequency of multinucleoside analogue-resistant genotypes observed during antiretroviral therapy
49. Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel
50. A retrospective study of neutropenia in HIV disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.